Ward stock vs patient-specific dispensing
Ward stock keeps medication available on the unit for any patient who needs it, optimising for speed. Patient-specific dispensing supplies each dose against a named patient and a verified order, optimising for traceability. The trade is direct: stock is fast and loses the link to the patient, patient-specific preserves the link and cannot be faster than the supply cycle.
Neither model is correct hospital-wide. The decision is per unit, and it is decided by how predictable that unit’s medication use is.
What does each model actually optimise?
Ward stock optimises the interval between deciding to treat and being able to treat. In an emergency department, an operating theatre or a deteriorating patient on any unit, that interval is a clinical variable, and stock exists because it is sometimes the variable that matters most.
Patient-specific dispensing optimises the integrity of the record. Every dose has a patient, an order and a release event attached before it reaches the bedside, which is what allows the loop to check anything downstream.
The reason both survive is that both are correct, for different questions. A hospital that eliminated stock in favour of patient-specific supply would have excellent records and a dangerous emergency department. A hospital that ran on stock alone would be fast and unable to reconcile anything.
What does ward stock actually cost you?
The patient link, at the exact stage where the loop needs it. A dose taken from stock enters the patient’s record only when someone documents it, which makes documentation the sole evidence rather than a confirmation of a release event.
Reconciliation. Stock is counted rather than transacted, so a discrepancy is a number at the end of a period with no starting point for an investigation. This is the mechanism behind most controlled-substance discrepancies that turn out not to be diversion — and it is also what makes the ones that are diversion hard to establish.
Expiry and waste, which is the unglamorous cost that shows up in the pharmacy budget rather than in a safety report.
And a specific error type: taking the right drug for the wrong patient from a shelf where the drug is organised by name. Nothing about that action is anomalous until it reaches a bedside scan, if there is one.
What does patient-specific dispensing cost you?
Responsiveness. A dose prepared against an order cannot be available before the order exists and has been verified, so the model has a floor set by pharmacy turnaround. On a unit where treatment decisions and administration are minutes apart, that floor is clinically unacceptable.
Rework. Orders change, and every change invalidates prepared doses. On a unit where regimens change several times a day the rework can exceed the preparation it replaced.
And a fallback requirement. Every patient-specific unit still needs a defined path for the dose that is needed now, because the alternative is staff inventing one. A model without a designed exception path gets an undesigned one.
How should you allocate by unit?
Predictability is the variable. Where medication use is scheduled, stable and known in advance, patient-specific supply captures nearly all of its benefit at nearly none of its cost — medical wards, rehabilitation, most surgical wards after the first day, long-term care.
Where medication use is unpredictable and time-critical, stock is the right answer and the effort should go into attribution instead: making removal authenticated, recorded against a patient where possible, and reconciled against administration afterwards. That is emergency, theatre, critical care, and labour.
Most units are mixed, and the practical arrangement is patient-specific supply for the scheduled regimen plus a defined stock list for the time-critical exceptions — with the override data reviewed regularly to see whether the stock list is right. That review is the mechanism that keeps the allocation honest as a unit’s case mix drifts.
Frequently asked
- What is the difference between ward stock and patient-specific dispensing?
- Ward stock keeps medication available on the unit for any patient who needs it, optimising the interval between deciding to treat and being able to treat. Patient-specific dispensing supplies each dose against a named patient and a verified order, optimising the integrity of the record. Stock is fast and loses the patient link; patient-specific preserves it and cannot be faster than the supply cycle.
- What are the risks of ward stock medication?
- The dose enters the patient record only when someone documents it, so documentation is the sole evidence rather than a confirmation of a release. Stock is counted rather than transacted, so discrepancies appear as a number at period end with no starting point for investigation. And taking the right drug for the wrong patient from a shelf organised by drug name looks entirely unremarkable until a bedside scan catches it.
- Which hospital units should use patient-specific dispensing?
- Units where medication use is scheduled, stable and known in advance — medical wards, rehabilitation, most surgical wards after the first day, and long-term care. Units with unpredictable, time-critical use should keep stock and invest in attribution instead: emergency, theatre, critical care and labour.
- Can a hospital run only patient-specific dispensing?
- Not safely. Every patient-specific unit still needs a defined path for a dose that is needed before an order can be verified, because staff will otherwise invent one. A model without a designed exception path gets an undesigned one, which is less safe than the stock arrangement it replaced.